

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid cycle (GO:0006099) | 5.71540874 |
| 2 | lysine metabolic process (GO:0006553) | 5.40746064 |
| 3 | lysine catabolic process (GO:0006554) | 5.40746064 |
| 4 | oxidative phosphorylation (GO:0006119) | 4.97056997 |
| 5 | NADH metabolic process (GO:0006734) | 4.94035078 |
| 6 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.75939176 |
| 7 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.75646638 |
| 8 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.67872964 |
| 9 | oxaloacetate metabolic process (GO:0006107) | 4.57767015 |
| 10 | establishment of integrated proviral latency (GO:0075713) | 4.45522130 |
| 11 | heme biosynthetic process (GO:0006783) | 4.39773674 |
| 12 | succinate metabolic process (GO:0006105) | 4.35578966 |
| 13 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.34859877 |
| 14 | cullin deneddylation (GO:0010388) | 4.33831327 |
| 15 | 2-oxoglutarate metabolic process (GO:0006103) | 4.28012110 |
| 16 | ribosome assembly (GO:0042255) | 4.22163905 |
| 17 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.21662930 |
| 18 | CENP-A containing nucleosome assembly (GO:0034080) | 4.18036399 |
| 19 | chromatin remodeling at centromere (GO:0031055) | 4.17549335 |
| 20 | valine metabolic process (GO:0006573) | 4.16597432 |
| 21 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.16341274 |
| 22 | ATP synthesis coupled proton transport (GO:0015986) | 4.16341274 |
| 23 | branched-chain amino acid catabolic process (GO:0009083) | 4.13338376 |
| 24 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.05151144 |
| 25 | aspartate family amino acid catabolic process (GO:0009068) | 4.03806383 |
| 26 | respiratory electron transport chain (GO:0022904) | 4.03764984 |
| 27 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.02509248 |
| 28 | protein deneddylation (GO:0000338) | 3.99505539 |
| 29 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.96913061 |
| 30 | negative regulation of ligase activity (GO:0051352) | 3.96913061 |
| 31 | heme metabolic process (GO:0042168) | 3.96004862 |
| 32 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.95055646 |
| 33 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.94511494 |
| 34 | tricarboxylic acid metabolic process (GO:0072350) | 3.94283544 |
| 35 | electron transport chain (GO:0022900) | 3.93098967 |
| 36 | branched-chain amino acid metabolic process (GO:0009081) | 3.92843698 |
| 37 | fatty acid beta-oxidation (GO:0006635) | 3.90310461 |
| 38 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.90238335 |
| 39 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.85444985 |
| 40 | DNA double-strand break processing (GO:0000729) | 3.84764496 |
| 41 | purine nucleobase biosynthetic process (GO:0009113) | 3.82478486 |
| 42 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.82090821 |
| 43 | glyoxylate metabolic process (GO:0046487) | 3.80277505 |
| 44 | IMP biosynthetic process (GO:0006188) | 3.77446631 |
| 45 | respiratory chain complex IV assembly (GO:0008535) | 3.68192639 |
| 46 | tetrapyrrole biosynthetic process (GO:0033014) | 3.67569031 |
| 47 | lactate metabolic process (GO:0006089) | 3.66963649 |
| 48 | DNA replication checkpoint (GO:0000076) | 3.63325551 |
| 49 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.63070393 |
| 50 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.59048345 |
| 51 | L-phenylalanine metabolic process (GO:0006558) | 3.59048345 |
| 52 | cysteine metabolic process (GO:0006534) | 3.58776043 |
| 53 | porphyrin-containing compound metabolic process (GO:0006778) | 3.57329109 |
| 54 | acetyl-CoA metabolic process (GO:0006084) | 3.55509076 |
| 55 | L-phenylalanine catabolic process (GO:0006559) | 3.54784598 |
| 56 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.54784598 |
| 57 | histone exchange (GO:0043486) | 3.54038546 |
| 58 | fatty acid oxidation (GO:0019395) | 3.53040012 |
| 59 | ethanol oxidation (GO:0006069) | 3.52951305 |
| 60 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.51099673 |
| 61 | mitotic metaphase plate congression (GO:0007080) | 3.50643197 |
| 62 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.50042483 |
| 63 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.49828072 |
| 64 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.49828072 |
| 65 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.49828072 |
| 66 | establishment of viral latency (GO:0019043) | 3.48052367 |
| 67 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.46240477 |
| 68 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.46152277 |
| 69 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.46152277 |
| 70 | aerobic respiration (GO:0009060) | 3.46092306 |
| 71 | lipid oxidation (GO:0034440) | 3.45845303 |
| 72 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.44068120 |
| 73 | fatty acid catabolic process (GO:0009062) | 3.43417531 |
| 74 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.42758597 |
| 75 | regulation of coenzyme metabolic process (GO:0051196) | 3.42681805 |
| 76 | regulation of cofactor metabolic process (GO:0051193) | 3.42681805 |
| 77 | chaperone-mediated protein transport (GO:0072321) | 3.41957625 |
| 78 | nucleobase biosynthetic process (GO:0046112) | 3.40573015 |
| 79 | DNA ligation (GO:0006266) | 3.40562165 |
| 80 | maturation of 5.8S rRNA (GO:0000460) | 3.40405923 |
| 81 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.37544140 |
| 82 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.37544140 |
| 83 | cellular ketone body metabolic process (GO:0046950) | 3.34519730 |
| 84 | positive regulation of ligase activity (GO:0051351) | 3.33411906 |
| 85 | rRNA modification (GO:0000154) | 3.32767426 |
| 86 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.32067803 |
| 87 | DNA strand elongation (GO:0022616) | 3.31521172 |
| 88 | IMP metabolic process (GO:0046040) | 3.31361181 |
| 89 | short-chain fatty acid metabolic process (GO:0046459) | 3.31249723 |
| 90 | aldehyde catabolic process (GO:0046185) | 3.29933207 |
| 91 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.27285342 |
| 92 | fatty acid transmembrane transport (GO:1902001) | 3.24971648 |
| 93 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.24005641 |
| 94 | carnitine shuttle (GO:0006853) | 3.22297904 |
| 95 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.21587077 |
| 96 | protein neddylation (GO:0045116) | 3.20716397 |
| 97 | amino-acid betaine metabolic process (GO:0006577) | 3.20375987 |
| 98 | NAD metabolic process (GO:0019674) | 3.18589811 |
| 99 | quinone biosynthetic process (GO:1901663) | 3.18476058 |
| 100 | ubiquinone biosynthetic process (GO:0006744) | 3.18476058 |
| 101 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.16606495 |
| 102 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.16562302 |
| 103 | DNA replication-independent nucleosome organization (GO:0034724) | 3.16562302 |
| 104 | metaphase plate congression (GO:0051310) | 3.16400046 |
| 105 | aromatic amino acid family catabolic process (GO:0009074) | 3.15708527 |
| 106 | non-recombinational repair (GO:0000726) | 3.14907054 |
| 107 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.14907054 |
| 108 | cytochrome complex assembly (GO:0017004) | 3.14573323 |
| 109 | regulation of ligase activity (GO:0051340) | 3.14134372 |
| 110 | protein localization to kinetochore (GO:0034501) | 3.14054436 |
| 111 | carnitine metabolic process (GO:0009437) | 3.12997904 |
| 112 | termination of RNA polymerase III transcription (GO:0006386) | 3.12619689 |
| 113 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.12619689 |
| 114 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.12501041 |
| 115 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.12501041 |
| 116 | alpha-linolenic acid metabolic process (GO:0036109) | 3.11254599 |
| 117 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.10921575 |
| 118 | kynurenine metabolic process (GO:0070189) | 3.09287646 |
| 119 | monocarboxylic acid catabolic process (GO:0072329) | 3.08005622 |
| 120 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.06559204 |
| 121 | DNA damage response, detection of DNA damage (GO:0042769) | 3.05363532 |
| 122 | regulation of sequestering of triglyceride (GO:0010889) | 3.05231604 |
| 123 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.99465785 |
| 124 | regulation of helicase activity (GO:0051095) | 2.99135167 |
| 125 | rRNA methylation (GO:0031167) | 2.97977116 |
| 126 | heart process (GO:0003015) | 2.97865631 |
| 127 | heart contraction (GO:0060047) | 2.97865631 |
| 128 | spindle checkpoint (GO:0031577) | 2.97563806 |
| 129 | sulfur amino acid catabolic process (GO:0000098) | 2.96617156 |
| 130 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.96127953 |
| 131 | biotin metabolic process (GO:0006768) | 2.95860624 |
| 132 | telomere maintenance via recombination (GO:0000722) | 2.94585564 |
| 133 | cellular respiration (GO:0045333) | 2.93150418 |
| 134 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.93012082 |
| 135 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.93012082 |
| 136 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.92358720 |
| 137 | protein targeting to mitochondrion (GO:0006626) | 2.91196737 |
| 138 | cell cycle G1/S phase transition (GO:0044843) | 2.90925401 |
| 139 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.90925401 |
| 140 | serine family amino acid biosynthetic process (GO:0009070) | 2.90375328 |
| 141 | aspartate family amino acid metabolic process (GO:0009066) | 2.89981133 |
| 142 | mitotic recombination (GO:0006312) | 2.89895342 |
| 143 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.89718907 |
| 144 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.89718907 |
| 145 | NADH dehydrogenase complex assembly (GO:0010257) | 2.89718907 |
| 146 | dicarboxylic acid metabolic process (GO:0043648) | 2.89240431 |
| 147 | amino acid activation (GO:0043038) | 2.89065054 |
| 148 | tRNA aminoacylation (GO:0043039) | 2.89065054 |
| 149 | alpha-amino acid catabolic process (GO:1901606) | 2.88694199 |
| 150 | glycine metabolic process (GO:0006544) | 2.88684290 |
| 151 | mitotic spindle checkpoint (GO:0071174) | 2.88556703 |
| 152 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.88252594 |
| 153 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.88252594 |
| 154 | tRNA aminoacylation for protein translation (GO:0006418) | 2.87755393 |
| 155 | ketone body metabolic process (GO:1902224) | 2.87657776 |
| 156 | serine family amino acid metabolic process (GO:0009069) | 2.87127841 |
| 157 | replication fork processing (GO:0031297) | 2.86929914 |
| 158 | pseudouridine synthesis (GO:0001522) | 2.86684319 |
| 159 | proteasome assembly (GO:0043248) | 2.86201980 |
| 160 | tryptophan catabolic process (GO:0006569) | 2.85708395 |
| 161 | indole-containing compound catabolic process (GO:0042436) | 2.85708395 |
| 162 | indolalkylamine catabolic process (GO:0046218) | 2.85708395 |
| 163 | regulation of cellular amine metabolic process (GO:0033238) | 2.82861210 |
| 164 | response to mercury ion (GO:0046689) | 2.82632139 |
| 165 | mitochondrial RNA metabolic process (GO:0000959) | 2.82318477 |
| 166 | carboxylic acid catabolic process (GO:0046395) | 2.81032771 |
| 167 | organic acid catabolic process (GO:0016054) | 2.81032771 |
| 168 | cofactor biosynthetic process (GO:0051188) | 2.78756854 |
| 169 | regulation of triglyceride catabolic process (GO:0010896) | 2.78262706 |
| 170 | ATP biosynthetic process (GO:0006754) | 2.78242232 |
| 171 | cellular amino acid catabolic process (GO:0009063) | 2.77843721 |
| 172 | regulation of sulfur metabolic process (GO:0042762) | 2.77503908 |
| 173 | ubiquinone metabolic process (GO:0006743) | 2.77304000 |
| 174 | bile acid biosynthetic process (GO:0006699) | 2.73650638 |
| 175 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.73228455 |
| 176 | protein complex biogenesis (GO:0070271) | 2.71813067 |
| 177 | amino acid salvage (GO:0043102) | 2.71510030 |
| 178 | L-methionine salvage (GO:0071267) | 2.71510030 |
| 179 | L-methionine biosynthetic process (GO:0071265) | 2.71510030 |
| 180 | oxidoreduction coenzyme metabolic process (GO:0006733) | 2.71065524 |
| 181 | AMP metabolic process (GO:0046033) | 2.70407216 |
| 182 | nicotinamide nucleotide metabolic process (GO:0046496) | 2.69505905 |
| 183 | pyridine nucleotide metabolic process (GO:0019362) | 2.69505905 |
| 184 | cofactor catabolic process (GO:0051187) | 2.68925964 |
| 185 | tryptophan metabolic process (GO:0006568) | 2.68559129 |
| 186 | regulation of mitochondrial translation (GO:0070129) | 2.67786487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.58603085 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.36147075 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.45860195 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.52425163 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.24261770 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.05077158 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.94378036 |
| 8 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.92887449 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.90593730 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.87771956 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.87263793 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.82342371 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.72027710 |
| 14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.71992412 |
| 15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.66431569 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.62047670 |
| 17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.56198367 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.44995501 |
| 19 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.43583621 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.40981421 |
| 21 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.36178790 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.31567351 |
| 23 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20331601 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.19164024 |
| 25 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.17939117 |
| 26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.12654888 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.02821878 |
| 28 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.96052977 |
| 29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.91342020 |
| 30 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.90192793 |
| 31 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.88314160 |
| 32 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.86146340 |
| 33 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.85492979 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.85149810 |
| 35 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.80959534 |
| 36 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.79636993 |
| 37 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75987681 |
| 38 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.75043643 |
| 39 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.65636986 |
| 40 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.63602016 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.62597402 |
| 42 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.61934319 |
| 43 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.61569691 |
| 44 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.61258237 |
| 45 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.55868511 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55061308 |
| 47 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.54911181 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51413487 |
| 49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.49459119 |
| 50 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48886387 |
| 51 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.47146148 |
| 52 | EWS_26573619_Chip-Seq_HEK293_Human | 1.46821060 |
| 53 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.46093214 |
| 54 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.45933092 |
| 55 | FUS_26573619_Chip-Seq_HEK293_Human | 1.45679490 |
| 56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45042367 |
| 57 | VDR_22108803_ChIP-Seq_LS180_Human | 1.40435279 |
| 58 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.40389438 |
| 59 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.40085458 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.39115240 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37433008 |
| 62 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.36392407 |
| 63 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.33724704 |
| 64 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.32851861 |
| 65 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.31793163 |
| 66 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.30739888 |
| 67 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.29892136 |
| 68 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.27631414 |
| 69 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.26683871 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.25557202 |
| 71 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.25199875 |
| 72 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24038797 |
| 73 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.23353840 |
| 74 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.23302876 |
| 75 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.22293128 |
| 76 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.18326406 |
| 77 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.14872912 |
| 78 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14110648 |
| 79 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.13060265 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12646837 |
| 81 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12200576 |
| 82 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.07546490 |
| 83 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06476311 |
| 84 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.04612609 |
| 85 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.04158469 |
| 86 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.03959271 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03461746 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03223608 |
| 89 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.02736936 |
| 90 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.02280098 |
| 91 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.02240339 |
| 92 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.01908453 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01617370 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01138573 |
| 95 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00946775 |
| 96 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.00539965 |
| 97 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.99819984 |
| 98 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.99793934 |
| 99 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.99589326 |
| 100 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.97884325 |
| 101 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.97241952 |
| 102 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96040423 |
| 103 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.94696446 |
| 104 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94043311 |
| 105 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92865346 |
| 106 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92236903 |
| 107 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.91906227 |
| 108 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91270837 |
| 109 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90853235 |
| 110 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89403326 |
| 111 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88719575 |
| 112 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.88629526 |
| 113 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87995412 |
| 114 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.87061518 |
| 115 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86557605 |
| 116 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.85798052 |
| 117 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.84141974 |
| 118 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.84061446 |
| 119 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.83743623 |
| 120 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.82780717 |
| 121 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.82460123 |
| 122 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82188392 |
| 123 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81691056 |
| 124 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80841546 |
| 125 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.80663707 |
| 126 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.79924729 |
| 127 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.79603022 |
| 128 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.79251132 |
| 129 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79046943 |
| 130 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.77607453 |
| 131 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.77071729 |
| 132 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.76572723 |
| 133 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.76535393 |
| 134 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.75661169 |
| 135 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.75235033 |
| 136 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.74621131 |
| 137 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.73048955 |
| 138 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.73003932 |
| 139 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.71930849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010094_abnormal_chromosome_stability | 4.31499586 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.27402254 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.25243018 |
| 4 | MP0008058_abnormal_DNA_repair | 4.04101097 |
| 5 | MP0005360_urolithiasis | 4.02679974 |
| 6 | MP0004147_increased_porphyrin_level | 3.83189664 |
| 7 | MP0003656_abnormal_erythrocyte_physiolo | 3.47498216 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.40300139 |
| 9 | MP0006036_abnormal_mitochondrial_physio | 3.35955445 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 3.26502454 |
| 11 | MP0003111_abnormal_nucleus_morphology | 3.17512317 |
| 12 | MP0005365_abnormal_bile_salt | 3.11363177 |
| 13 | MP0003646_muscle_fatigue | 3.06727221 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.79362948 |
| 15 | MP0008057_abnormal_DNA_replication | 2.76542765 |
| 16 | MP0003941_abnormal_skin_development | 2.68121975 |
| 17 | MP0003718_maternal_effect | 2.67790968 |
| 18 | MP0003186_abnormal_redox_activity | 2.65229302 |
| 19 | MP0003077_abnormal_cell_cycle | 2.63467068 |
| 20 | MP0008007_abnormal_cellular_replicative | 2.52699934 |
| 21 | MP0004084_abnormal_cardiac_muscle | 2.49944657 |
| 22 | MP0008932_abnormal_embryonic_tissue | 2.48358608 |
| 23 | MP0003195_calcinosis | 2.46342080 |
| 24 | MP0005332_abnormal_amino_acid | 2.37997025 |
| 25 | MP0003786_premature_aging | 2.34466399 |
| 26 | MP0004215_abnormal_myocardial_fiber | 2.33443306 |
| 27 | MP0000749_muscle_degeneration | 2.32927166 |
| 28 | MP0010329_abnormal_lipoprotein_level | 2.12243649 |
| 29 | MP0005330_cardiomyopathy | 2.11815384 |
| 30 | MP0004036_abnormal_muscle_relaxation | 2.05830010 |
| 31 | MP0004130_abnormal_muscle_cell | 2.01247922 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.98588049 |
| 33 | MP0006035_abnormal_mitochondrial_morpho | 1.97498450 |
| 34 | MP0001764_abnormal_homeostasis | 1.96509810 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.96243013 |
| 36 | MP0002938_white_spotting | 1.83193462 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.81445279 |
| 38 | MP0009840_abnormal_foam_cell | 1.78285990 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 1.77387738 |
| 40 | MP0000751_myopathy | 1.76832895 |
| 41 | MP0000372_irregular_coat_pigmentation | 1.74138000 |
| 42 | MP0005083_abnormal_biliary_tract | 1.73390019 |
| 43 | MP0008775_abnormal_heart_ventricle | 1.72297331 |
| 44 | MP0002102_abnormal_ear_morphology | 1.70399234 |
| 45 | MP0006072_abnormal_retinal_apoptosis | 1.67138892 |
| 46 | MP0005670_abnormal_white_adipose | 1.66116227 |
| 47 | MP0003890_abnormal_embryonic-extraembry | 1.63233815 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.62285188 |
| 49 | MP0000609_abnormal_liver_physiology | 1.58127914 |
| 50 | MP0003221_abnormal_cardiomyocyte_apopto | 1.55710987 |
| 51 | MP0004043_abnormal_pH_regulation | 1.54942006 |
| 52 | MP0001529_abnormal_vocalization | 1.54922397 |
| 53 | MP0002269_muscular_atrophy | 1.54070801 |
| 54 | MP0006054_spinal_hemorrhage | 1.50173442 |
| 55 | MP0003252_abnormal_bile_duct | 1.49274468 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 1.46264025 |
| 57 | MP0002118_abnormal_lipid_homeostasis | 1.45780133 |
| 58 | MP0001293_anophthalmia | 1.42199031 |
| 59 | MP0001730_embryonic_growth_arrest | 1.39647743 |
| 60 | MP0005266_abnormal_metabolism | 1.39184411 |
| 61 | MP0002090_abnormal_vision | 1.38532142 |
| 62 | MP0001544_abnormal_cardiovascular_syste | 1.35782161 |
| 63 | MP0005385_cardiovascular_system_phenoty | 1.35782161 |
| 64 | MP0002972_abnormal_cardiac_muscle | 1.35200419 |
| 65 | MP0004087_abnormal_muscle_fiber | 1.34151203 |
| 66 | MP0000750_abnormal_muscle_regeneration | 1.29550198 |
| 67 | MP0009697_abnormal_copulation | 1.26216770 |
| 68 | MP0001666_abnormal_nutrient_absorption | 1.24455547 |
| 69 | MP0005620_abnormal_muscle_contractility | 1.22634393 |
| 70 | MP0005379_endocrine/exocrine_gland_phen | 1.20220265 |
| 71 | MP0001697_abnormal_embryo_size | 1.20206217 |
| 72 | MP0000747_muscle_weakness | 1.20139843 |
| 73 | MP0002876_abnormal_thyroid_physiology | 1.20079738 |
| 74 | MP0001756_abnormal_urination | 1.17948981 |
| 75 | MP0000516_abnormal_urinary_system | 1.17700142 |
| 76 | MP0005367_renal/urinary_system_phenotyp | 1.17700142 |
| 77 | MP0003011_delayed_dark_adaptation | 1.15994749 |
| 78 | MP0003121_genomic_imprinting | 1.15181246 |
| 79 | MP0002332_abnormal_exercise_endurance | 1.14645396 |
| 80 | MP0005408_hypopigmentation | 1.13578563 |
| 81 | MP0001853_heart_inflammation | 1.11929182 |
| 82 | MP0002138_abnormal_hepatobiliary_system | 1.11601855 |
| 83 | MP0000343_altered_response_to | 1.11396377 |
| 84 | MP0005376_homeostasis/metabolism_phenot | 1.11177508 |
| 85 | MP0000350_abnormal_cell_proliferation | 1.10057093 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 1.08955490 |
| 87 | MP0005666_abnormal_adipose_tissue | 1.08693774 |
| 88 | MP0010307_abnormal_tumor_latency | 1.07574639 |
| 89 | MP0000598_abnormal_liver_morphology | 1.06729162 |
| 90 | MP0002106_abnormal_muscle_physiology | 1.05961672 |
| 91 | MP0009672_abnormal_birth_weight | 1.05688638 |
| 92 | MP0001984_abnormal_olfaction | 1.05273172 |
| 93 | MP0006138_congestive_heart_failure | 1.04405008 |
| 94 | MP0002163_abnormal_gland_morphology | 1.04149378 |
| 95 | MP0001672_abnormal_embryogenesis/_devel | 1.03158812 |
| 96 | MP0005380_embryogenesis_phenotype | 1.03158812 |
| 97 | MP0002971_abnormal_brown_adipose | 1.02842240 |
| 98 | MP0003937_abnormal_limbs/digits/tail_de | 1.01433432 |
| 99 | MP0002084_abnormal_developmental_patter | 0.99270606 |
| 100 | MP0008469_abnormal_protein_level | 0.98982822 |
| 101 | MP0000230_abnormal_systemic_arterial | 0.98610561 |
| 102 | MP0003123_paternal_imprinting | 0.98391490 |
| 103 | MP0005535_abnormal_body_temperature | 0.97811807 |
| 104 | MP0002160_abnormal_reproductive_system | 0.97268202 |
| 105 | MP0005395_other_phenotype | 0.97000062 |
| 106 | MP0001929_abnormal_gametogenesis | 0.96831847 |
| 107 | MP0004019_abnormal_vitamin_homeostasis | 0.96619665 |
| 108 | MP0002078_abnormal_glucose_homeostasis | 0.96571967 |
| 109 | MP0002254_reproductive_system_inflammat | 0.96115470 |
| 110 | MP0010630_abnormal_cardiac_muscle | 0.96077651 |
| 111 | MP0005253_abnormal_eye_physiology | 0.95357633 |
| 112 | MP0005075_abnormal_melanosome_morpholog | 0.95144876 |
| 113 | MP0006292_abnormal_olfactory_placode | 0.93623833 |
| 114 | MP0010234_abnormal_vibrissa_follicle | 0.92302865 |
| 115 | MP0002080_prenatal_lethality | 0.90404597 |
| 116 | MP0000759_abnormal_skeletal_muscle | 0.89434100 |
| 117 | MP0002085_abnormal_embryonic_tissue | 0.87911506 |
| 118 | MP0008995_early_reproductive_senescence | 0.87311066 |
| 119 | MP0003122_maternal_imprinting | 0.86925068 |
| 120 | MP0008789_abnormal_olfactory_epithelium | 0.86705091 |
| 121 | MP0002210_abnormal_sex_determination | 0.86053152 |
| 122 | MP0005220_abnormal_exocrine_pancreas | 0.85688953 |
| 123 | MP0003693_abnormal_embryo_hatching | 0.85450378 |
| 124 | MP0000653_abnormal_sex_gland | 0.85260134 |
| 125 | MP0003984_embryonic_growth_retardation | 0.83067390 |
| 126 | MP0004957_abnormal_blastocyst_morpholog | 0.82990930 |
| 127 | MP0002088_abnormal_embryonic_growth/wei | 0.82148840 |
| 128 | MP0002233_abnormal_nose_morphology | 0.81894482 |
| 129 | MP0005334_abnormal_fat_pad | 0.81447278 |
| 130 | MP0001145_abnormal_male_reproductive | 0.81294745 |
| 131 | MP0009763_increased_sensitivity_to | 0.80924093 |
| 132 | MP0000358_abnormal_cell_content/ | 0.79540894 |
| 133 | MP0009642_abnormal_blood_homeostasis | 0.78593894 |
| 134 | MP0002396_abnormal_hematopoietic_system | 0.78588525 |
| 135 | MP0009764_decreased_sensitivity_to | 0.78502563 |
| 136 | MP0000313_abnormal_cell_death | 0.77820581 |
| 137 | MP0000647_abnormal_sebaceous_gland | 0.76650423 |
| 138 | MP0004233_abnormal_muscle_weight | 0.76491058 |
| 139 | MP0005369_muscle_phenotype | 0.76334946 |
| 140 | MP0004484_altered_response_of | 0.74522990 |
| 141 | MP0004133_heterotaxia | 0.73602871 |
| 142 | MP0003315_abnormal_perineum_morphology | 0.73442347 |
| 143 | MP0003137_abnormal_impulse_conducting | 0.73324431 |
| 144 | MP0002970_abnormal_white_adipose | 0.73302802 |
| 145 | MP0003119_abnormal_digestive_system | 0.73260740 |
| 146 | MP0005084_abnormal_gallbladder_morpholo | 0.72827141 |
| 147 | MP0005165_increased_susceptibility_to | 0.71894466 |
| 148 | MP0003724_increased_susceptibility_to | 0.71342581 |
| 149 | MP0005551_abnormal_eye_electrophysiolog | 0.70647405 |
| 150 | MP0001286_abnormal_eye_development | 0.70615803 |
| 151 | MP0005058_abnormal_lysosome_morphology | 0.70509043 |
| 152 | MP0001119_abnormal_female_reproductive | 0.70487325 |
| 153 | MP0002736_abnormal_nociception_after | 0.69960205 |
| 154 | MP0009780_abnormal_chondrocyte_physiolo | 0.69590530 |
| 155 | MP0002751_abnormal_autonomic_nervous | 0.69362355 |
| 156 | MP0005397_hematopoietic_system_phenotyp | 0.66194153 |
| 157 | MP0001545_abnormal_hematopoietic_system | 0.66194153 |
| 158 | MP0002136_abnormal_kidney_physiology | 0.65572928 |
| 159 | MP0001765_abnormal_ion_homeostasis | 0.65423769 |
| 160 | MP0001661_extended_life_span | 0.64863225 |
| 161 | MP0008872_abnormal_physiological_respon | 0.64689208 |
| 162 | MP0003567_abnormal_fetal_cardiomyocyte | 0.62882260 |
| 163 | MP0002132_abnormal_respiratory_system | 0.61943872 |
| 164 | MP0009115_abnormal_fat_cell | 0.61288241 |
| 165 | MP0009785_altered_susceptibility_to | 0.59743622 |
| 166 | MP0005647_abnormal_sex_gland | 0.58245998 |
| 167 | MP0004085_abnormal_heartbeat | 0.57525992 |
| 168 | MP0009333_abnormal_splenocyte_physiolog | 0.56682090 |
| 169 | MP0005451_abnormal_body_composition | 0.55643514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatic necrosis (HP:0002605) | 4.67968599 |
| 2 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.47116568 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.19461537 |
| 4 | Hepatocellular necrosis (HP:0001404) | 4.14897048 |
| 5 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.12524632 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.11012391 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 4.06921402 |
| 8 | Acute encephalopathy (HP:0006846) | 4.05453019 |
| 9 | Myoglobinuria (HP:0002913) | 3.95987033 |
| 10 | Cerebral edema (HP:0002181) | 3.86380943 |
| 11 | Increased CSF lactate (HP:0002490) | 3.77436080 |
| 12 | Mitochondrial inheritance (HP:0001427) | 3.76127410 |
| 13 | Abnormality of glycolysis (HP:0004366) | 3.72074842 |
| 14 | Increased serum pyruvate (HP:0003542) | 3.72074842 |
| 15 | Dicarboxylic aciduria (HP:0003215) | 3.59745718 |
| 16 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.59745718 |
| 17 | Generalized aminoaciduria (HP:0002909) | 3.59520547 |
| 18 | Hyperammonemia (HP:0001987) | 3.59332572 |
| 19 | Rhabdomyolysis (HP:0003201) | 3.58519580 |
| 20 | Hyperglycinuria (HP:0003108) | 3.57298662 |
| 21 | Increased muscle lipid content (HP:0009058) | 3.53979859 |
| 22 | Nausea (HP:0002018) | 3.48817681 |
| 23 | Ketosis (HP:0001946) | 3.45164536 |
| 24 | Ketoacidosis (HP:0001993) | 3.43713406 |
| 25 | Lactic acidosis (HP:0003128) | 3.41272251 |
| 26 | Progressive macrocephaly (HP:0004481) | 3.32305493 |
| 27 | Methylmalonic acidemia (HP:0002912) | 3.31885146 |
| 28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.29536476 |
| 29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.29536476 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.25284663 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 3.25284663 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.23398032 |
| 33 | Exercise-induced muscle cramps (HP:0003710) | 3.19394636 |
| 34 | Increased intramyocellular lipid droplets (HP:0012240) | 3.18518329 |
| 35 | Lethargy (HP:0001254) | 3.12531084 |
| 36 | Increased serum lactate (HP:0002151) | 3.10831553 |
| 37 | Abnormality of the labia minora (HP:0012880) | 3.07431156 |
| 38 | Abnormality of alanine metabolism (HP:0010916) | 3.07331798 |
| 39 | Hyperalaninemia (HP:0003348) | 3.07331798 |
| 40 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.07331798 |
| 41 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.02611721 |
| 42 | Cholelithiasis (HP:0001081) | 3.01980226 |
| 43 | Palpitations (HP:0001962) | 3.01260689 |
| 44 | Metabolic acidosis (HP:0001942) | 2.94138658 |
| 45 | Hyperbilirubinemia (HP:0002904) | 2.91580340 |
| 46 | Hypobetalipoproteinemia (HP:0003563) | 2.90732524 |
| 47 | Hyperglycinemia (HP:0002154) | 2.88596955 |
| 48 | Lipid accumulation in hepatocytes (HP:0006561) | 2.86780511 |
| 49 | Abnormal gallbladder morphology (HP:0012437) | 2.83448373 |
| 50 | Ragged-red muscle fibers (HP:0003200) | 2.81730628 |
| 51 | Respiratory failure (HP:0002878) | 2.76064887 |
| 52 | Exercise intolerance (HP:0003546) | 2.75565647 |
| 53 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.72827595 |
| 54 | Meckel diverticulum (HP:0002245) | 2.72654149 |
| 55 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.67289338 |
| 56 | Vomiting (HP:0002013) | 2.66248234 |
| 57 | Proximal tubulopathy (HP:0000114) | 2.65940231 |
| 58 | Renal Fanconi syndrome (HP:0001994) | 2.65876894 |
| 59 | Abnormality of serum amino acid levels (HP:0003112) | 2.65715107 |
| 60 | Colon cancer (HP:0003003) | 2.62859427 |
| 61 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.62573507 |
| 62 | Exercise-induced myalgia (HP:0003738) | 2.62473065 |
| 63 | Abnormality of chromosome stability (HP:0003220) | 2.62413239 |
| 64 | CNS demyelination (HP:0007305) | 2.61306815 |
| 65 | Poikilocytosis (HP:0004447) | 2.61206375 |
| 66 | Abnormality of the ileum (HP:0001549) | 2.58408700 |
| 67 | Type I transferrin isoform profile (HP:0003642) | 2.54172966 |
| 68 | Conjunctival hamartoma (HP:0100780) | 2.54171740 |
| 69 | Abnormality of urine glucose concentration (HP:0011016) | 2.51192463 |
| 70 | Glycosuria (HP:0003076) | 2.51192463 |
| 71 | Intrahepatic cholestasis (HP:0001406) | 2.50424812 |
| 72 | Gout (HP:0001997) | 2.49812226 |
| 73 | Chromsome breakage (HP:0040012) | 2.49067413 |
| 74 | Xanthomatosis (HP:0000991) | 2.48769033 |
| 75 | Hypoglycemic seizures (HP:0002173) | 2.45669718 |
| 76 | Megaloblastic anemia (HP:0001889) | 2.44739201 |
| 77 | Abnormality of the anterior horn cell (HP:0006802) | 2.42542121 |
| 78 | Degeneration of anterior horn cells (HP:0002398) | 2.42542121 |
| 79 | Increased hepatocellular lipid droplets (HP:0006565) | 2.41082604 |
| 80 | Abnormality of vitamin B metabolism (HP:0004340) | 2.40730302 |
| 81 | Abnormality of the preputium (HP:0100587) | 2.38725103 |
| 82 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.37298086 |
| 83 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.35964729 |
| 84 | Cholecystitis (HP:0001082) | 2.32319037 |
| 85 | Abnormal gallbladder physiology (HP:0012438) | 2.32319037 |
| 86 | Reticulocytosis (HP:0001923) | 2.31647214 |
| 87 | Hypolipoproteinemia (HP:0010981) | 2.30930875 |
| 88 | Abnormal lung lobation (HP:0002101) | 2.30393625 |
| 89 | Microvesicular hepatic steatosis (HP:0001414) | 2.29809842 |
| 90 | Esophageal neoplasm (HP:0100751) | 2.27594368 |
| 91 | Neoplasm of head and neck (HP:0012288) | 2.27594368 |
| 92 | Multiple enchondromatosis (HP:0005701) | 2.26035707 |
| 93 | Neuroendocrine neoplasm (HP:0100634) | 2.26027425 |
| 94 | Ependymoma (HP:0002888) | 2.25008210 |
| 95 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.23542468 |
| 96 | 3-Methylglutaconic aciduria (HP:0003535) | 2.23203523 |
| 97 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.18439794 |
| 98 | Reduced antithrombin III activity (HP:0001976) | 2.17065157 |
| 99 | Abnormality of purine metabolism (HP:0004352) | 2.16615081 |
| 100 | Leukodystrophy (HP:0002415) | 2.16454127 |
| 101 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.16224664 |
| 102 | Abnormal number of erythroid precursors (HP:0012131) | 2.15746673 |
| 103 | Pheochromocytoma (HP:0002666) | 2.15671963 |
| 104 | Calf muscle hypertrophy (HP:0008981) | 2.14568479 |
| 105 | Methylmalonic aciduria (HP:0012120) | 2.13416004 |
| 106 | Acanthocytosis (HP:0001927) | 2.13017212 |
| 107 | Deep venous thrombosis (HP:0002625) | 2.12943207 |
| 108 | Sudden death (HP:0001699) | 2.12189497 |
| 109 | Lipoatrophy (HP:0100578) | 2.11799423 |
| 110 | Renal cortical cysts (HP:0000803) | 2.10562308 |
| 111 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.10315359 |
| 112 | Hyperlipoproteinemia (HP:0010980) | 2.09607058 |
| 113 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.06217187 |
| 114 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.06217187 |
| 115 | Abnormal protein glycosylation (HP:0012346) | 2.06217187 |
| 116 | Abnormal glycosylation (HP:0012345) | 2.06217187 |
| 117 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.05145076 |
| 118 | Ventricular tachycardia (HP:0004756) | 2.04765277 |
| 119 | Prolonged partial thromboplastin time (HP:0003645) | 2.04601323 |
| 120 | Neoplasm of the adrenal gland (HP:0100631) | 2.04353926 |
| 121 | Hypothermia (HP:0002045) | 2.04132475 |
| 122 | Abnormality of the gallbladder (HP:0005264) | 2.04034150 |
| 123 | Birth length less than 3rd percentile (HP:0003561) | 2.03521543 |
| 124 | Increased serum ferritin (HP:0003281) | 2.03232739 |
| 125 | Exertional dyspnea (HP:0002875) | 2.03027906 |
| 126 | Small intestinal stenosis (HP:0012848) | 2.02607615 |
| 127 | Duodenal stenosis (HP:0100867) | 2.02607615 |
| 128 | Abnormality of nucleobase metabolism (HP:0010932) | 2.00341269 |
| 129 | Dilated cardiomyopathy (HP:0001644) | 2.00167634 |
| 130 | Hyperuricemia (HP:0002149) | 1.99822262 |
| 131 | Increased purine levels (HP:0004368) | 1.99822262 |
| 132 | Rhabdomyosarcoma (HP:0002859) | 1.97945849 |
| 133 | Abnormality of the duodenum (HP:0002246) | 1.97777752 |
| 134 | Symptomatic seizures (HP:0011145) | 1.97123150 |
| 135 | Abnormality of methionine metabolism (HP:0010901) | 1.96679052 |
| 136 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.95623024 |
| 137 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.95130245 |
| 138 | Hypoalphalipoproteinemia (HP:0003233) | 1.94888974 |
| 139 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.87306793 |
| 140 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.87306793 |
| 141 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.84911302 |
| 142 | Abnormality of vitamin metabolism (HP:0100508) | 1.84262049 |
| 143 | Optic disc pallor (HP:0000543) | 1.84135494 |
| 144 | Respiratory difficulties (HP:0002880) | 1.82524638 |
| 145 | Intestinal atresia (HP:0011100) | 1.81466577 |
| 146 | Bifid tongue (HP:0010297) | 1.76438566 |
| 147 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.75948803 |
| 148 | Ovarian neoplasm (HP:0100615) | 1.75907792 |
| 149 | Posterior subcapsular cataract (HP:0007787) | 1.74996550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.35329283 |
| 2 | EIF2AK1 | 4.03330656 |
| 3 | PDK4 | 3.51278285 |
| 4 | PDK3 | 3.51278285 |
| 5 | NME2 | 3.32688076 |
| 6 | NEK1 | 3.29079673 |
| 7 | VRK2 | 3.00190768 |
| 8 | TRIM28 | 2.82234095 |
| 9 | OBSCN | 2.71572711 |
| 10 | MYLK | 2.57187787 |
| 11 | TTK | 2.55435437 |
| 12 | PLK3 | 2.42953270 |
| 13 | SRPK1 | 2.33448418 |
| 14 | MKNK2 | 2.23567198 |
| 15 | FLT3 | 2.21457526 |
| 16 | TTN | 2.12207341 |
| 17 | PINK1 | 2.10236202 |
| 18 | PDK2 | 2.08419357 |
| 19 | EIF2AK3 | 2.07760729 |
| 20 | STK16 | 2.07265140 |
| 21 | BUB1 | 2.00672884 |
| 22 | PKN2 | 1.97439065 |
| 23 | MKNK1 | 1.96500570 |
| 24 | PLK4 | 1.91868149 |
| 25 | NUAK1 | 1.88806811 |
| 26 | WNK3 | 1.84558371 |
| 27 | NEK9 | 1.77357550 |
| 28 | BMPR1B | 1.72449916 |
| 29 | KDR | 1.72038251 |
| 30 | TRIB3 | 1.68633641 |
| 31 | NME1 | 1.62837594 |
| 32 | WEE1 | 1.62055697 |
| 33 | MAP2K3 | 1.53485199 |
| 34 | ERBB3 | 1.50740753 |
| 35 | SCYL2 | 1.43460280 |
| 36 | PLK1 | 1.41485231 |
| 37 | TNIK | 1.39599956 |
| 38 | TAF1 | 1.38956050 |
| 39 | ACVR1B | 1.38617361 |
| 40 | MAP4K2 | 1.38416797 |
| 41 | BRSK2 | 1.37622038 |
| 42 | LMTK2 | 1.36323297 |
| 43 | PIM2 | 1.34180595 |
| 44 | PHKG2 | 1.28859556 |
| 45 | PHKG1 | 1.28859556 |
| 46 | FRK | 1.28130212 |
| 47 | PIK3CG | 1.27615772 |
| 48 | ERN1 | 1.24817183 |
| 49 | STK24 | 1.15839391 |
| 50 | CSNK1G1 | 1.14577938 |
| 51 | MUSK | 1.14559022 |
| 52 | TIE1 | 1.13403525 |
| 53 | MAP3K11 | 1.10156711 |
| 54 | BCR | 1.09588485 |
| 55 | PLK2 | 1.07152834 |
| 56 | TSSK6 | 1.06508061 |
| 57 | LRRK2 | 1.04028587 |
| 58 | MAPKAPK3 | 0.97783448 |
| 59 | CSNK1G3 | 0.96537030 |
| 60 | ZAK | 0.95404363 |
| 61 | VRK1 | 0.94599982 |
| 62 | ABL2 | 0.93737562 |
| 63 | TYK2 | 0.92440554 |
| 64 | PAK4 | 0.92121337 |
| 65 | PIK3CA | 0.91724372 |
| 66 | OXSR1 | 0.89133260 |
| 67 | MAPK11 | 0.87523827 |
| 68 | ILK | 0.87266320 |
| 69 | PASK | 0.86808794 |
| 70 | MAP3K3 | 0.83449424 |
| 71 | ATR | 0.83422229 |
| 72 | GRK1 | 0.82952754 |
| 73 | STK39 | 0.80171052 |
| 74 | TGFBR1 | 0.80042611 |
| 75 | BRSK1 | 0.79828368 |
| 76 | TBK1 | 0.79597954 |
| 77 | CSNK1G2 | 0.79481557 |
| 78 | MST4 | 0.71713414 |
| 79 | STK3 | 0.69213959 |
| 80 | STK4 | 0.69030906 |
| 81 | WNK4 | 0.68139553 |
| 82 | CHEK2 | 0.66364367 |
| 83 | PNCK | 0.66233797 |
| 84 | CSNK1A1L | 0.65361593 |
| 85 | MAPK12 | 0.65198556 |
| 86 | CCNB1 | 0.64911793 |
| 87 | JAK3 | 0.64610794 |
| 88 | CDC7 | 0.61655051 |
| 89 | ATM | 0.60310216 |
| 90 | ALK | 0.59363535 |
| 91 | MAP3K12 | 0.59242150 |
| 92 | SIK1 | 0.58981527 |
| 93 | TRPM7 | 0.57469700 |
| 94 | TGFBR2 | 0.56193136 |
| 95 | STK38L | 0.55060712 |
| 96 | ERBB4 | 0.53686440 |
| 97 | LIMK1 | 0.53242443 |
| 98 | TESK1 | 0.52888631 |
| 99 | INSRR | 0.51986183 |
| 100 | JAK2 | 0.51607521 |
| 101 | MAP3K5 | 0.51358502 |
| 102 | ARAF | 0.50962503 |
| 103 | FGFR1 | 0.50949370 |
| 104 | MAP2K6 | 0.49945509 |
| 105 | ZAP70 | 0.47546537 |
| 106 | MAP4K1 | 0.47090147 |
| 107 | AURKB | 0.46723310 |
| 108 | KIT | 0.45772063 |
| 109 | CDK7 | 0.44103241 |
| 110 | FGFR2 | 0.44092913 |
| 111 | FGFR4 | 0.44064067 |
| 112 | CHEK1 | 0.43778795 |
| 113 | TAOK2 | 0.43172094 |
| 114 | GRK7 | 0.42222582 |
| 115 | PIM1 | 0.42071022 |
| 116 | TEC | 0.41940549 |
| 117 | EIF2AK2 | 0.41917010 |
| 118 | NLK | 0.41890921 |
| 119 | PRKCI | 0.41852385 |
| 120 | CSNK2A1 | 0.40043662 |
| 121 | PRKAA1 | 0.39632855 |
| 122 | DAPK3 | 0.38569255 |
| 123 | SIK3 | 0.37166217 |
| 124 | PBK | 0.36982127 |
| 125 | MAP3K8 | 0.36278446 |
| 126 | MAP2K1 | 0.36087400 |
| 127 | PRKCE | 0.35694447 |
| 128 | PRKACG | 0.35227358 |
| 129 | FER | 0.35206666 |
| 130 | PRKAA2 | 0.35119606 |
| 131 | PRKCG | 0.35088662 |
| 132 | RPS6KL1 | 0.34970226 |
| 133 | RPS6KC1 | 0.34970226 |
| 134 | STK10 | 0.34890151 |
| 135 | RPS6KA4 | 0.34748618 |
| 136 | RPS6KA6 | 0.34652428 |
| 137 | DYRK3 | 0.34243601 |
| 138 | IRAK3 | 0.33761933 |
| 139 | NEK2 | 0.33327033 |
| 140 | TESK2 | 0.33102635 |
| 141 | SYK | 0.32798312 |
| 142 | AURKA | 0.32615126 |
| 143 | CSNK1E | 0.32397528 |
| 144 | DAPK1 | 0.30845763 |
| 145 | TLK1 | 0.30713545 |
| 146 | RPS6KB2 | 0.30703749 |
| 147 | CDK4 | 0.30121292 |
| 148 | CSNK2A2 | 0.28755034 |
| 149 | DYRK2 | 0.27939237 |
| 150 | CAMKK2 | 0.26716630 |
| 151 | MAPKAPK5 | 0.26457709 |
| 152 | CDK3 | 0.25958145 |
| 153 | PAK3 | 0.25418405 |
| 154 | CSNK1A1 | 0.25080601 |
| 155 | PRKDC | 0.23320181 |
| 156 | CAMK2D | 0.23188866 |
| 157 | CDK8 | 0.23149359 |
| 158 | CDK1 | 0.23070659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.38683194 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.50802456 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.05447380 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86452098 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.82321147 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.77232992 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.76996666 |
| 8 | Carbon metabolism_Homo sapiens_hsa01200 | 2.44341551 |
| 9 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.41981812 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.36492896 |
| 11 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.36482939 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.32722156 |
| 13 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.16148127 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.13395798 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 2.09867764 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.83210134 |
| 17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.81156070 |
| 18 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.80890619 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.76676645 |
| 20 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.74815012 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.72652995 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.72628842 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.70071293 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.69577850 |
| 25 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.65378568 |
| 26 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.62350801 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.59354677 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.52440291 |
| 29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.51998668 |
| 30 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.51014656 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.50822585 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.48528021 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47140646 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46766659 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.42439161 |
| 36 | Alzheimers disease_Homo sapiens_hsa05010 | 1.39184330 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.36899918 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31608727 |
| 39 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28727565 |
| 40 | DNA replication_Homo sapiens_hsa03030 | 1.28371687 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.24877890 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24688412 |
| 43 | Ribosome_Homo sapiens_hsa03010 | 1.24483155 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23087219 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.22730262 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19741910 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.19601435 |
| 48 | Cell cycle_Homo sapiens_hsa04110 | 1.18951848 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12738643 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.12590586 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.12499410 |
| 52 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07508945 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07459900 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06849821 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06395201 |
| 56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.01744161 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.00175400 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98419592 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.96460623 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96425556 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93957774 |
| 62 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.93331919 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92143552 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91510405 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91483819 |
| 66 | Protein export_Homo sapiens_hsa03060 | 0.90911698 |
| 67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.88237446 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86454436 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.84488249 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82089072 |
| 71 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81943084 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81632676 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79588669 |
| 74 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77085094 |
| 75 | RNA polymerase_Homo sapiens_hsa03020 | 0.74651262 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73149297 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68189217 |
| 78 | Mismatch repair_Homo sapiens_hsa03430 | 0.67616516 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66765652 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61992482 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57397493 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.55390854 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52466474 |
| 84 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.51993109 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51315724 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50838302 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.50670059 |
| 88 | Purine metabolism_Homo sapiens_hsa00230 | 0.47078662 |
| 89 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47030139 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46789155 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.43828490 |
| 92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42523498 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42208311 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42203860 |
| 95 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.38752792 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.37453315 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32739786 |
| 98 | RNA transport_Homo sapiens_hsa03013 | 0.28095809 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | 0.26889228 |
| 100 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.26604905 |
| 101 | Legionellosis_Homo sapiens_hsa05134 | 0.25288915 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20036565 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.17613971 |
| 104 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.17533579 |
| 105 | Homologous recombination_Homo sapiens_hsa03440 | 0.17077932 |
| 106 | RNA degradation_Homo sapiens_hsa03018 | 0.15830253 |
| 107 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.15165716 |
| 108 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.15156239 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.14164793 |
| 110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.13161175 |
| 111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.13020666 |
| 112 | Spliceosome_Homo sapiens_hsa03040 | 0.13010386 |
| 113 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.11938251 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | 0.11618398 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11596147 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.11039238 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.10872629 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.09536911 |

